Research & Development

久久爱在线播放视频日本天堂网av在线观看av天天堂在线观看日本伟创力响应美禁令中断与华为合作 季度利润暴跌


  太宰急切的希望雲瑯開始籌劃反漢復秦大計,即便是不能立刻執行,也需要處理迫在眉睫的秦陵安全問題。   雲瑯聳聳肩膀道︰“他們要把我買進男風館,小子自然送他們去地獄。”久久爱在线播放视频   “你去听課了?”日本天堂网av在线观看   “昨日你還沒有醒來,我走了,老鼠都能咬死你。”   梁甲皺眉道︰“我們難道就不能一起把人跟鹿一起賣掉最後平分錢財嗎?”av天天堂在线观看日本   平叟不明白,一個被師門驅逐,被宗族排擠的破落戶眼光為何會如此之高。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo